Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of interferon gamma-1b (Gamarek/Gammarec) in sepsis patients in intensive care
IRCT20180610040037N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2023
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of interferon gamma-1b in sepsis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: recovery, death and 1 more. Started Mar 2023; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20180610040037N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180610040037N3.